StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CV

CapsoVision, Inc.

CV Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗
$7.17
+0.47 +7.01%

Key statistics

from XBRL data in SEC filings
Market cap
$358M
Revenue (TTM)
$13.6M
Net income (TTM)
-$27.0M
EPS (TTM)
$1.31
P/E ratio
5.5
Dividend yield
Free cash flow
-$23.0M
Cash
Total assets
$25.9M
Gross margin
51.7%
52-week range
$3.43 – $15.37

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Regulation FD disclosure Jul 2, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure; Other events Mar 20, 2026 8-K Entered a material agreement Mar 13, 2026 8-K Other events Dec 29, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Other events Nov 10, 2025 8-K Director or officer change; Regulation FD disclosure Nov 3, 2025 8-K Director or officer change Sep 26, 2025 8-K Director or officer change Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Other events Jul 18, 2025 8-K Entered a material agreement; Amended charter or bylaws; Other events Jul 3, 2025
Other filings
4 PRIMARY DOCUMENT Jul 21, 2026 4 PRIMARY DOCUMENT Jul 10, 2026 4 PRIMARY DOCUMENT Jul 7, 2026 4 FORM 4 Jul 2, 2026 3 FORM 3 Jul 2, 2026 4 FORM 4 Jul 1, 2026 4/A FORM 4/A Jul 1, 2026 4 FORM 4 Jul 1, 2026 4 FORM 4 Jul 1, 2026 4 FORM 4 Jul 1, 2026 4 FORM 4 Jul 1, 2026 4 FORM 4 Jul 1, 2026 4 FORM 4 Jun 3, 2026 4 FORM 4 Jun 3, 2026 4 FORM 4 Jun 3, 2026 SCHEDULE 13G/A May 6, 2026 4 FORM 4 May 6, 2026 DEF 14A Apr 28, 2026 424B3 Apr 23, 2026 EFFECT Apr 22, 2026 CORRESP Apr 17, 2026